Acta Med. 1999, 42: 69-72

https://doi.org/10.14712/18059694.2019.145

Influencing of Spatial Memory in Rats by DSP-4 and Mescaline

Marie Koupilováa, Josef Herinka, Otakar Krsb

aPurkyně Military Medical Academy, Hradec Králové, Department of Toxicology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Anatomy, Hradec Králové, Czech Republic

References

1. Abe K, Horiuchi M, Yoshimura K. Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrainlesioned rats. Eur J Pharmacol 1997; 321:149-55. <https://doi.org/10.1016/S0014-2999(96)00934-X>
2. Altman HL, Stone WS, rgen SO. Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval. Behav Neural Biol 1987; 48:49-62. <https://doi.org/10.1016/S0163-1047(87)90574-7>
3. Davis WM and Hatoum HL. Comparison of stimulants and hallucinogens on shuttle avoidance. Gen Pharmac 1987; 18:123-8. <https://doi.org/10.1016/0306-3623(87)90237-0>
4. Delini-Stula A, Mogilnicka E, Hunn C, Dooley DJ. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projection by DSP-4, a new noradrenergic neurotoxin. Pharmacol Biochem Behav 1984; 20:613-8. <https://doi.org/10.1016/0091-3057(84)90312-5>
5. Fritschy JM, Geffard M, Grzanna R. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine hydroxylase. J Chem Neuroanat 1990; 3:309-21.
6. Gibson CJ. Inhibition of MAO B, but no MAO A, blocks DSP-4 toxicity on central NE neurons. European J Pharmacol 1987; 141:135-8. <https://doi.org/10.1016/0014-2999(87)90420-1>
7. Grzanna R, Berger U, Fritschy JM, Geffard M. Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects. J Histochem Cytochem 1989; 37:1435-42. <https://doi.org/10.1177/37.9.2768812>
8. Herink J, Koupilová M, Krs O, Bajgar J, Patočka J. Modelling of some neuropathological states of the central nervous system by aziridine derivatives. Cesk Fyziol 1992; 41:7-10.
9. Jaim-Etcheverry G and Zieher LH. DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats. Brain Res 1980; 188:513-23. <https://doi.org/10.1016/0006-8993(80)90049-9>
10. Koupilová M and Herink J. Effects of mescaline and its derivative N-(3,4,5-trimethoxyphenylethyl)-aziridine on the spatial orientation of rats in a T-maze. Physiol Bohemoslov 1989; 38:497-502.
11. Koupilová M, Herink J, Bajgar J. Effects of aziridine derivative N-(3,5-dimethoxy-4-propoxyphenylethyl)-aziridine on learning and memory in laboratory rats. Homeostasis 1993; 34:117-9.
12. Moran PM, Le Maitre MH, Philouze V, Reyman JM, Allain H, Leonard BE. Reversal of learning and memory impairment following lesion of the nucleus basalis magnocellularis (NMB) by concurrent noradrenergic depletion using DSP-4 in the rat. Brain Res 1992; 595:327-33. <https://doi.org/10.1016/0006-8993(92)91067-O>
13. Morley MJ, Shah K, Bradshaw CM, Szabadi E. DSP-4 and Herrnsteins equation: further evidence for a role of noradrenaline in the maintenance of operant behaviour by positive reinforcement. Psychopharmacology 1988; 96:551-6. <https://doi.org/10.1007/BF02180039>
14. Ohno M, Yoshimatsu A, Kobayashi M, Watanabe S. Noradrenergic DSP-4 lesions aggravate impairment of working memory produced by hippocampal muscarinic blockade in rats. Pharmacol Biochem Behav 1997; 57:257-61. <https://doi.org/10.1016/S0091-3057(96)00353-X>
15. Santucci AC, Haroutunian V, Davis KL. Pharmacological alleviation of combined cholinenergic/noradrenergic lesion-induced memory deficits in rats. Clin Neuropharmacol 1991; 14:1-8. <https://doi.org/10.1097/00002826-199114001-00002>
16. Sirvi J, Riekkinen JrP, Valjaka A, Jolkkonen J, Riekkinen PJ. The effects of noradrenergic neurotoxin, DSP-4, on the performance of young ang aged rats in spatial navigation task. Brain Res 1991; 563:297-302. <https://doi.org/10.1016/0006-8993(91)91550-K>
17. Takasuna M, Iwasaki T. Active and passive avoidance learning in rats neonatally treated with intraventricular 6-hydroxydopamine. Behav Brain Res 1996;74: 119-26. <https://doi.org/10.1016/0166-4328(95)00148-4>
18. Toledano-Gasca A. Hypothesis concerning the etiology of Alzheimers disease. Pharmacopsychiat. 1988; 21:17-25. <https://doi.org/10.1055/s-2007-1017060>
19. Tuček S, Doležal V, Nedoma J. Cholinergic mechanisms in the brain. Activ Nerv Sup (Praha) 1986; 28:42-3.
20. Zagrodska J, Wieczorek M, Romaniuk A. Social interactions in rats: behavioral and neurochemical alterations in DSP-4 - treated rats. Pharmacol Biochem Behav 1994; 49:541-8. <https://doi.org/10.1016/0091-3057(94)90066-3>
21. al-Zahrani SS, al-Ruwaitea AS, Ho MY, Bradshaw CM, Szabadi E. Destruction of central noradrenergic neurones with DSP-4 impairs the acquisition of temporal discrimination but does not affect memory for duration in a delayed conditional discrimination task. Psychopharmacology (Berl) 1997; 130:166-73. <https://doi.org/10.1007/s002130050225>
22. Zieher LM and Jaim-Etcheverry G. Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP-4) on noradrenergic neurons is mimicked by its cyclic aziridinium derivative. Eur J Pharmacol 1980; 65:249-52. <https://doi.org/10.1016/0014-2999(80)90398-2>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive